Chewy reported Q2 sales slightly below consensus but raised its full-year revenue and adjusted EBITDA margin outlook. This mixed performance led to varied analyst reactions, with some downgrading or cutting price targets while others maintained positive ratings.
Chewy's Q2 results presented a mixed bag: sales slightly missed expectations, but the company's raised full-year outlook for both revenue and adjusted EBITDA margin signals management's confidence. This dichotomy led to a split among analysts, with some downgrading or lowering price targets due to the sales miss and others maintaining positive ratings, albeit with adjusted price targets. The immediate market reaction was a slight pre-market dip, indicating some investor caution. Long-term implications depend on Chewy's ability to execute on its raised guidance and deepen customer engagement, as highlighted by the CEO. For traders, the key risk is continued sales deceleration, while the opportunity lies in the company's improved profitability outlook and recurring revenue base.